BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

FDA Approves Mirum and Incyte’s Atebrioz for Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz...

September 28, 2026 | News

CooperVision Opens Global Innovation Hub in UK, Unveils Six Contact Lens Advancements

CooperVision today unveiled the grand opening of The Vision Centre, the company's new global innovation hub in Southampton, England, and announced si...

September 25, 2026 | News

Turbine, Daiichi Sankyo Expand Virtual Biology Collaboration to Accelerate ADC Discovery

Turbine, a leading virtual biology company, announced the expansion of its collaboration with Daiichi Sankyo following the successful completio...

September 25, 2026 | News

Bio-Techne Shareholders Approve Acquisition by Merck KGaA

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne ...

September 25, 2026 | News

European Commission Approves First-in-Class Obicetrapib for LDL-C Reduction

- First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions with favorable tolerability...

September 25, 2026 | News

Bio-Techne Opens Düsseldorf Flagship Centre to Accelerate Life Sciences Innovation Across Europe

New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and ...

September 24, 2026 | News

NewAmsterdam, Menarini Secure EU Approval for Obicetrapib-Based Ubeslo and Evlarco

NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company developing oral, non-s...

September 23, 2026 | News

IMPACT Therapeutics, Pharmanovia’s Senaparib Secures EU Panel Backing for Ovarian Cancer

MPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based...

September 21, 2026 | News

Daiichi Sankyo, AstraZeneca’s Enhertu Wins EU Panel Backing for Early Breast Cancer

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% vers...

September 21, 2026 | News

OGT Expands SureSeq NGS Indexing Capacity to 384 Samples per Run

OGT, a leading global provider of genomic research and diagnostic solutions, announced the expansion of its SureSeq™ Universal NGS Unique Dual Index ...

September 21, 2026 | News

Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO

Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TAT...

September 16, 2026 | News

Bausch + Lomb Secures European CE Mark for Next-Generation SeeLyra Femtosecond Laser

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, announced European C...

September 14, 2026 | News

Celltrion Launches 300 mg Omlyclo Omalizumab Biosimilar Across Key European Markets

Omlyclo® (omalizumab) 300 mg launched in key European markets including Germany, the UK and France, with rollout to expand across Europe by ye...

August 26, 2026 | News

SingHealth Launches Global Fellowship Network to Develop Future-Ready Healthcare Leaders

SingHealth is working alongside nine leading academic medical centres and health systems worldwide to formalise a structured exchange programme for healt...

August 14, 2026 | News

Stay Connected